Key regions: France, Brazil, South Korea, India, China
The Antiviral Drugs market in Ireland has been showing positive growth in recent years.
Customer preferences: The demand for antiviral drugs in Ireland is driven by several factors, including an increase in the prevalence of viral infections such as HIV, hepatitis B and C, and influenza. Additionally, the aging population in Ireland is also contributing to the growth of the antiviral drugs market, as older individuals are more susceptible to viral infections and require more medical attention.
Trends in the market: One of the major trends in the antiviral drugs market in Ireland is the increasing use of combination therapies. Combination therapies involve the use of multiple antiviral drugs to treat a single infection, and have been shown to be more effective than single-drug therapies. Another trend in the market is the development of new antiviral drugs that are more effective and have fewer side effects. This is driving innovation in the market and providing new treatment options for patients.
Local special circumstances: One of the unique factors influencing the antiviral drugs market in Ireland is the country's healthcare system. Ireland has a public healthcare system, which means that many patients receive their antiviral drugs for free or at a reduced cost. This has led to high demand for antiviral drugs, as patients are more likely to seek treatment when it is affordable. Additionally, the Irish government has been investing in research and development in the healthcare sector, which has led to the development of new antiviral drugs and therapies.
Underlying macroeconomic factors: The growth of the antiviral drugs market in Ireland is also influenced by broader macroeconomic factors. For example, the Irish economy has been growing steadily in recent years, which has led to increased investment in the healthcare sector. Additionally, the country's membership in the European Union has provided access to a larger market for Irish pharmaceutical companies, which has driven innovation and growth in the sector. Overall, the antiviral drugs market in Ireland is expected to continue to grow in the coming years, driven by demographic factors, technological innovation, and favorable macroeconomic conditions.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
